Vir Biotech partners with WuXi on COVID-19 antibody treatment
27-02-2020
motortion films / Shutterstock.com
Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application. Antibody experts and European patent attorneys Tom Leonard, Alison Care and Dave Wortley from law firm Kilburn & Strode joined WIPR group editor Tom Phillips for a webinar on the latest developments in antibody patenting yesterday, August 5.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
antibodies, patents, Europe, patent applications, EPO, prosecution, drugs, claims, filing, antibody
